Jazz Pharmaceuticals Plc
(NASDAQ : JAZZ)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading JAZZ News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-7.91%166.039.9%$682.82m
VRXValeant Pharmaceuticals International, Inc.
-8.85%20.287.1%$590.12m
PRGOPerrigo Co. Plc
-4.44%90.974.0%$246.55m
ENDPEndo International Plc
-6.25%14.854.1%$131.38m
JAZZJazz Pharmaceuticals Plc
-4.90%137.902.7%$122.88m
ICPTIntercept Pharmaceuticals, Inc.
-7.35%142.9213.8%$89.19m
MNKMallinckrodt Plc
-4.85%55.8711.7%$88.70m
RLYPRelypsa, Inc.
-3.65%17.4333.0%$69.06m
HZNPHorizon Pharma plc
-6.82%16.259.7%$64.47m
UTHRUnited Therapeutics Corporation
-3.01%102.1119.5%$61.35m
MDCOMedicines Company
-3.71%33.2619.6%$47.24m
CTLTCatalent Inc
-3.76%22.774.1%$46.79m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-6.54%83.3112.2%$37.71m
ICLRICON Plc
0.31%67.623.3%$35.57m
ALRAlere Inc.
-2.14%41.674.7%$30.41m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded on January 18, 2012 and is headquartered in Dublin, Ireland.